Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Frey

Showing results (441-450 of 475) with videos related to

Pageof 48
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 5, 2023
Influence of <i>CYP2C19</i>, <i>CYP2D6</i>, and <i>ABCB1</i> Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) StudyFarhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND reportNikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
JAMA Psychiatry|February 11, 2026
One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in DepressionAndre C Tonon, Adile Nexha, Jasmyn E A Cunningham, et al.
Psychoneuroendocrinology|July 6, 2021
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study reportJee Su Suh, Laura M Fiori, Mohammad Ali, et al.
Translational Psychiatry|February 16, 2021
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant responseVictoria S Marshe, Malgorzata Maciukiewicz, Anne-Christin Hauschild, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 29, 2025
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1Leen Magarbeh, Samar S M Elsheikh, Farhana Islam, et al.
Bipolar Disorders|June 26, 2021
Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task ForceRalph Kupka, Anne Duffy, Jan Scott, et al.
Neuroimage|May 11, 2019
Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participantsNikita Nogovitsyn, Roberto Souza, Meghan Muller, et al.
The New England Journal of Medicine|August 2, 2023
Duration of Adjunctive Antidepressant Maintenance in Bipolar I DepressionLakshmi N Yatham, Shyam Sundar Arumugham, Muralidharan Kesavan, et al.
JAMA Network Open|January 4, 2020
Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With DepressionAndrey Zhdanov, Sravya Atluri, Willy Wong, et al.
Pageof 48

Showing results (441-450 of 475) with videos related to

Sort By:
Pageof 48
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 5, 2023
Influence of <i>CYP2C19</i>, <i>CYP2D6</i>, and <i>ABCB1</i> Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) StudyFarhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND reportNikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
JAMA Psychiatry|February 11, 2026
One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in DepressionAndre C Tonon, Adile Nexha, Jasmyn E A Cunningham, et al.
Psychoneuroendocrinology|July 6, 2021
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study reportJee Su Suh, Laura M Fiori, Mohammad Ali, et al.
Translational Psychiatry|February 16, 2021
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant responseVictoria S Marshe, Malgorzata Maciukiewicz, Anne-Christin Hauschild, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 29, 2025
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1Leen Magarbeh, Samar S M Elsheikh, Farhana Islam, et al.
Bipolar Disorders|June 26, 2021
Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task ForceRalph Kupka, Anne Duffy, Jan Scott, et al.
Neuroimage|May 11, 2019
Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participantsNikita Nogovitsyn, Roberto Souza, Meghan Muller, et al.
The New England Journal of Medicine|August 2, 2023
Duration of Adjunctive Antidepressant Maintenance in Bipolar I DepressionLakshmi N Yatham, Shyam Sundar Arumugham, Muralidharan Kesavan, et al.
JAMA Network Open|January 4, 2020
Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With DepressionAndrey Zhdanov, Sravya Atluri, Willy Wong, et al.
Pageof 48